InhaTarget Therapeutics
PrivateLast Round
Series A
Extension
Jun 1, 2022
Total Funding Raised
$7.49M
Company Overview
InhaTarget Therapeutics is a biotechnology company that develops innovative inhalation formulations for the treatment of severe respiratory diseases and lung cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InhaTarget Therapeutics Comparables
Compare InhaTarget Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quench Medical | 83% | |
| Nob Hill Therapeutics | 78% | |
| Ethris | 77% | |
InhaTarget Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 1, 2022 | ||||
| Series A Extension | Dec 1, 2019 |
Key People
Founding team and executive leadership
InhaTarget Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fremoluc | Series A Extension |
| Sambrinvest | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2019
$4M round with investors Fremoluc and Sambrinvest.
InhaTarget Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InhaTarget Therapeutics's valuation, stock price, and market status.